Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Telesis Bio

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports First Quarter 2024 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Reverse Stock Split
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Third Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Appoints William J. Kullback Chief Financial Officer
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Second Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Jefferies Healthcare Conference 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Secures Financing of $28.0 Million
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at SynBioBeta 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports First Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Festival of Biologics Conference
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.